Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So glad I jumped on some of those .122s. Sitting pretty now. I'm cool with it going from the .12s to .24s over and over and over again.
That was my initial thought but not having known this company for very long I figured it would be better to ask around as I like to know the companies I may invest in before doing so. Thanks for the info btw.
I'm trying to find a good entry point not knowing much about this company other than what I've been able to find to read. Any insights or warnings? Trying to find out why a company that has revenue coming in and seems to be in the positive is so low. $AMMX
Ahh feel like today was successful. Finally have a bit more of a holding here. Now to wait, watch and who knows maybe add more.
Although I agree. Paid PR is kind of snaky, mainly because I don't trust any PR 100%, almost all companies and businesses do this. So acting like paying for PR is the worst thing in the world is a bit overstated lmao. We get it, you don't like it, okay. Point taken. :) $POTN
I got one luckily but it's definitely far off from when we were talking about this in the .03s on the FRLF board haha.
Put a bid in at .185 while it was at .20 not thinking I'd get them. A few moments later it dropped and filled it. I'll take them but definitely a surprise.
A little dip? ;)
I'm not doing anything but sharing a piece of news that I found this AM. I'm not interpreting it in any way lol. I'm literally just sharing information. Paid for by whoever, it was posted, I read it, and I shared it. That's all, take with it what you will lmao.
Take it however you like my friend. I'm merely sharing a piece of news I found.
$POTN - Speculative Buy Rating and 12 month Price target of $1.25
Harbinger Research Initiates Coverage on PotNetwork Holding, Inc. (POTN – OTC Pink) With a Strong Speculative Buy Rating and a 12-month price target of $1.25 per sharePress Release | 03/08/2018
NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Harbinger Research, LLC, an equity research boutique based in Atlanta, GA initiated research coverage PotNetwork Holding (OTC PINK: POTN) today with a Strong Speculative Buy, and a $1.25 price target. Harbinger Research will be providing ongoing research coverage on POTN over at least the next 12 months.
Analyst Brian Connell, CFA, who covers the Company, stated "We are very pleased to have such a rapidly growing company with such a dynamic management team as part of our coverage universe. The cannabis industry is growing very rapidly, and we expect that this will continue for several years to come. As a first-mover and emerging market leader in many of its business lines, we believe this will clearly benefit PotNetwork Holding."
Dr. Richard E. Goulding, M.D., PotNetwork Holding's CEO, stated that "We are very pleased to have additional research coverage provided by a firm such as Harbinger Research. We have experienced solid success at bringing growth to the Cannabis industry over the past few quarters, and we are looking forward to having Harbinger and firms like it help keep the investment community up to date regarding our progress."
To view the Harbinger Research Coverage Initiation report, please click here: https://d1io3yog0oux5.cloudfront.net/harbingerresearch/media/02b2064a2bd7158c4340a7102969c84c.pdf
About Harbinger Research, LLC
Harbinger Research is an independent equity research that employs a research team consisting entirely of CFA Charterholders and follows a number of companies across a wide variety of industries. Harbinger Research makes all of its reports available through its website at www.harbingerresearch.com, and also distributes content through a variety of partners, including Thomson Reuters, InvestorsInsight Publishing, and through several other major financial portals.
About Diamond CBD, Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD's team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.
About PotNetwork Inc.: PotNetwork Inc. brings to market PotNetwork.com, a counter-culture, cutting-edge digital magazine, publishing up-to-date news and articles on the cannabis industry. PotNetwork Inc. operates as a wholly owned subsidiary of the Company; PotNetwork.com is a media resource providing a full range of industry related topics.
About PotNetwork Holding, Inc: PotNetwork Holding Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils, and PotNetwork.com.
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.
Yeah these OTC markets are way too volatile too do that. I suppose its a good idea if you have a tough time knowing when to cut your losses but I've never had that issue.
I agree. I feel like only lazy traders, people who don't know when to walk away, or traders with a vast amount of stocks should use them. I would much rather make decisions on my own considering I feel like I do enough research on my investments to know when I should or shouldn't do something.
What's a stop loss...Hehe :)
True, so I guess what we may be missing is those being included because they are, in fact, not officially completed yet?
Just a question but didn't they buy a few companies that were producing revenue? I don't believe I saw any of those present on the 10Q.
I believe they asked for an extension for a late filing actually. Not 100% on that but I do believe I read that somewhere.
I did the same from the .04s. I sold just enough to get my money back out when it was running to keep the rest I've got as practically free shares. Love me some free shares haha.
Electronic Juice? For E-Cigarettes? That's my best guess, not really sure though haha.
The shear amount of uses that this device has/will have could make it one of the most vital pieces of medical equipment in the world. The potential here is amazingly high and one I'm glad I'll be along for the ride with.
Hemp Provides Investors Access to Larger Cannabidiol Market
1 hour 4 minutes ago - DJNF -
NEW YORK, February 8, 2018 /PRNewswire/ --
NetworkNewsWire Editorial Coverage
With the rapid growth of the legal American cannabis market, other cannabidiol (CBD)-based products are often overlooked. In particular, hemp has the opportunity to reach medical and nutritional customers that cannabis can't, and ChineseInvestors.com (OTC: CIIX) (CIIX Profile) is tapping into that market. With the potential to provide similar benefits without the same restrictions, hemp products can be sold in markets such as China, where cannabis remains illegal. It's a part of the market that CBD industry leaders such as Freedom Leaf, Inc. (OTC: FRLF) are also catering to, with marketing and media products for hemp companies. Medical Marijuana, Inc. (OTC: MJNA), America's first publicly traded cannabis company, is carrying its CBD business beyond the United States and across the Americas, while CV Sciences, Inc. (OTC: CVSI) combines scientific research with a consumer products division to bring innovative CBD products to the market. At the farming end of the supply chain, Terra Tech Corp. (OTC: TRTC) provides advanced agricultural solutions and new, better strains of cannabis for a growing market.
The Growing Cannabidiol Market
The market for legal marijuana is growing at an ever-accelerating rate. Recent research by Arcview Market Research and BDS Analytics indicates that sales in North America reached almost $10 billion in 2017 and are expected to reach $24.5 billion by 2021 as more markets are created for both medical and recreational use. But this is still a sector threatened by great uncertainties and limitations. With no legal cannabis market in many parts of the globe, and with the current U.S. administration dominated by anti-marijuana conservatives, legal marijuana represents the troubled part of a larger CBD market.
For companies looking to that wider market, hemp offers a growing option for the CBD industry, one unfettered by many of the restrictions limiting marijuana. A report by the Brightfield Group shows that hemp is likely to become a billion-dollar market in the next three years. Used like cannabis in medicinal and nutritional products, it benefits from a high portion of online purchases - nearly two-thirds of hemp sales happen online.
Hemp also has the potential to reach larger international markets. The American-led war on drugs has encouraged an international climate that's hostile to cannabis sales, but in which hemp products mostly remain legal.
Bringing Cannabidiol Products to China
One of the companies best set to make the most of this opportunity is ChineseInvestors (OTCQB: CIIX).
Founded in 1999, ChineseInvestors.com is a leading financial information website for Chinese-speaking investors in both the United States and China. Through its website, the company offers a range of investor information and services, including real-time market commentary, analysis and educational products. It also provides support services for companies looking to get into the Chinese market, including consulting for companies considering going public, advertising services and public relations-related support. With information in both English and Chinese language character sets, it provides an accessible presentation for investors looking at China both from the inside and the outside.
This is built around the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. In this way, CIIX helps investors make informed investment decisions and helps them meet their individualized financial goals. This includes a division committed to cryptocurrencies (http://nnw.fm/3pwZV), producing daily videos to inform Chinese investors about this ever-growing and unregulated sector of the Chinese economy.
Its position at the intersection of American and Chinese markets has put CIIX in a perfect position to explore the wider cannabidiol market. Marijuana use is illegal in China, but CBD oils, including hemp-based CBDs, are legal. CIIX is committed to developing and distributing hemp-based products in hopes of helping people improve their overall health, targeting epilepsy, Alzheimer's disease, cirrhosis of the liver and various other health conditions. With nearly 10 million epilepsy patients in China, products that can help these customers have the potential to become big sellers in a growing market.
In December 2016, CIIX reached a wholesale agreement with a CBD health brand. Off the back of this, it launched its new subsidiary ChineseCBDoil.com. This website went live on Jan. 31, 2017, providing the world's first Chinese language online store for CBD health products. It provides a variety of nutritional supplements containing CBD, including soft gels, capsules and concentrates available to Chinese-speaking customers worldwide.
Though the company has emphasized the health benefits of CBD products, it is also leveraging its financial and marketing expertise to sell hemp-infused skin care products in China.
Sales thus far have been so successful that the company is spinning off its subsidiary - CBD Biotechnology and ChineseHempOil.com, Inc. - with the intention of listing the new company's common stock on the OTCQB (http://nnw.fm/Mxi3e). The site offers a variety of hemp oil products, including OptHemp Ultra Premium oil, peppermint-flavored hemp oil in softgels and gummies, and the Gold Plus line of premium hemp oil.
CIIX CEO Warren Wang expressed his confidence in this new development, stating in a press release, "We are excited to announce our intention to spin off CBD Biotechnology and ChineseHempOil.com, Inc. as we believe the existing business lines and the new acquisitions in China, secured by CEO Summer Yun, will allow these entities to continue to grow in their respective markets, while bringing new value to the Company's existing shareholders."
Growth and Challenges in America
The company's hemp-based health products are available in the United States and Canada. Wang aims to double the company's revenue and expand the business in 2018, with growth in North America as well as China. One of the tools to achieve this is a Yelp-style app for CBD customers. Approved for download by the Apple App Store, it is the world's first Chinese-language mobile cannabis navigation application. The app carries an easily searchable database of marijuana dispensaries and cannabis strains. Customers can use the platform to review and discuss cannabis products, allowing them to find the best recommendations and nearby locations for medical and recreational cannabis. This will broaden the company's reach and raise its profile in the growing number of states where marijuana is legally accessible.
CIIX is committed to further research into the use of hemp oil and other CBD products. The company in investing in research and design enterprises with the goal of developing CBD drugs to combat epilepsy and Alzheimer's disease. The application period for new drugs of this type in China is two to four years, meaning that the company will be able to bring products to market far more quickly than in the United States. If this research pays off, then the company will not only be providing new uses for products in a growth sector of the economy, it will also be in position to launch them in the largest customer market in the world.
Because CBD remains classified as a Schedule 1 drug under the Controlled Substance Act administered in the United States by the Drug Enforcement Administration, hemp sales are regarded as illegal by the federal government despite the growing number of states legalizing it under their authority. Schedule 1 drugs are identified as substances with a high potential for abuse, no currently accepted medical use in the United States and a lack of safety protocols under medical supervision (http://nnw.fm/Nm4CO). This prohibition is being challenged in court, and that challenge now has the backing of a cross-party group of Congress members. The Congressional group's arguments to the court state that the DEA's ruling on CBD was an "abuse of DEA's administrative procedure and rulemaking authority" and contrary to the definition of hemp set down by legislators in the 2014 Farm Bill (http://nnw.fm/Y2EPp). With such strong political support, the hemp industry is optimistic that this case will result in clarity and a lifting of the restrictions to permit easier expansion of CBD-based sales for companies such as CIIX.
The Cannabis Industry Connection
The deep connection between hemp production and the wider cannabis industry is shown by the work of companies such as Freedom Leaf (OTCQB: FRLF). A leading media producer and distributor in the cannabis and hemp industries, Freedom Leaf is a trusted source of information in the sector. The company is involved in mergers and acquisitions in the marijuana industry and has a portfolio of news, print and digital multi-media verticals, websites and web advertising, establishing it as a media outlet and discussion forum for a growing group of industries. It also provides services in branding, licensing and marketing these products, positioning it to make the most of fast growth in this sector. $FRLF
I linked the news to one of my previous posts if you want to check it out.
I know right, breaking news!!!! Call the press!!!!
I just find it funny that people on these boards think that their posts affect any of our actions. Everything on these boards I take with a grain of salt, good or bad. I can assure you, you're not important enough that I'd make investment decisions based on your posts. As I wouldn't expect you to make them based on my posts lmao.
Lmao yeah savvy is the word...
$FRLF - Green Market Europe, S.L. Acquisition effective as of January 5, 2018 and Filed today with the SEC.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12522529
Haha you beat me to it but yeah sounds like good news as well.
I'm still kicking myself on that RXMD. Starting investigating it right before it took off from .015.
Why is there going to be a continued downtrend? I want to know why you feel that way. Not just your opinion but is that opinion fact based? Serious question.
Found a little news article about the hemp and CBD market. Published 2/5/18
https://research.scottrade.com/qnr/Public/Stocks/News?symbol=70372324
True. I meant it as it could be a sign of things to come or maybe not. I have no idea, definitely not an expert in market conditions.
Seems like a small pullback. I read somewhere this was the worst week in 2 years.
Same here but I think we may be on the upswing. My bet is that it crawls back up before close.
Dead clock is right twice a day.
That's no joke, I'm still kicking myself for not buying more when it dropped from .042 to .04 haha.
Although for us buyers, .15 wouldn't be the worst thing.
Yeah, seems to be down just about everywhere. Best thing is just hold or if people can, add. At least that's my motto haha.
It's hard not to at this point.
First post to the board but have been watching BTHCF for a few years now. Reload those coffers!!
First post on the board but did we not expect a pullback at some point? I'm not worried, just along for the ride as this is all basically free money after those .04s :) I will admit though this was a pretty large pullback haha. Definitely a good time to reload the coffers IMO.